Kawasaki disease;La maladie de Kawasaki

Revue du Praticien

Volumn 57, Issue 18, 2007, Pages 1985-1988

  Cimaz, Rolando ^b   Lega, Jean Christophe ^a  

^a UNIVERSITÉ LYON 1   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

CERVICAL LYMPHADENOPATHY; CHILD HEALTH; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DEVELOPED COUNTRY; FEVER; HUMAN; ISCHEMIC HEART DISEASE; MICROORGANISM; MOUTH CAVITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; RACE DIFFERENCE; RASH; REVIEW; RISK FACTOR;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HEART DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MUCOCUTANEOUS LYMPH NODE SYNDROME; TIME FACTORS;

EID: 37149035265     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 2004;110:2747-71.
2. Falcini F, Cimaz R, Calabri GB, et al. Kawasaki disease in northern Italy: a multicenter data collection of 250 patients. Clin Exp Rheumatol 2002;20:421-6.
3. Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002;360:1197-202.
4. Harnden A, Alves B. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 2002;324:1424-5.
5. Holman RC, Curns AT. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003;112:495-501.
6. Yanagawa H, Nakamura Y. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:E33.
7. Pannaraj PS, Turner CL, Bastian JF, Burns JC. Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J 2004;23:789-91.
8. Cheung YF, Yung TC, Tam SC, et al. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 2004;43:120-4.
9. Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle B. Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr 2001;138:400-5.
10. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography is equivalent to X-Ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol 2004;43:649-52.
11. Leung DYM, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 2002;140:742-6.
12. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001;166:1334-43.
13. Esper F, Shapiro ED, Weibel C, et al. Association between a novel human Coronavirus and Kawasaki Disease. J Infect Dis 2005;191:499-502.
14. Levy DM, Silverman D, Massicotte P, et al. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol 2005;32:928-34.
15. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 2000;83:307-11.
16. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gammaglobulin dose but independent of salicylate dose. J Pediatr 1997;131:888-93.
17. Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics 2005;116:989-95.